SCHEMBL30425392

SCHEMBL30425392

FC(F)c1nnc(-c2ccc(Cn3cc(-c4ccc5[nH]c(N6CCOCC6)nc5c4)nn3)cc2)o1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 3/20 0.50
▸ CDC7 O00311 4/20 0.48
▸ ROCK2 O75116 5/20 0.41
▸ GSK3B P49841 5/20 0.41
▸ TP53 P04637 1/20 0.41
▸ FLT3 P36888 1/20 0.40
▸ PIM1 P11309 4/20 0.40
▸ AURKB Q96GD4 4/20 0.40
▸ KDR P35968 1/20 0.40
▸ PLK4 O00444 1/20 0.38
▸ AURKA O14965 1/20 0.38
▸ CHUK O15111 1/20 0.38
▸ MAPK13 O15264 1/20 0.38
▸ DAPK3 O43293 1/20 0.38
▸ JAK2 O60674 1/20 0.38
▸ CHEK2 O96017 1/20 0.38
▸ PRKCG P05129 1/20 0.38
▸ CDK1 P06493 1/20 0.38
▸ FGFR1 P11362 1/20 0.38
▸ PRKACA P17612 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25260165 1.00 HDAC6 (0.50) HDAC6CDC7ROCK2GSK3BTP53
SCHEMBL25214498 0.93 HDAC6 (0.50) HDAC6CDC7ROCK2GSK3BTP53
SCHEMBL25267504 0.87 HDAC6 (0.51) HDAC6CDC7ROCK2GSK3BTP53
SCHEMBL25215233 0.84 HDAC6 (0.52) HDAC6CDC7ROCK2GSK3BFLT3
SCHEMBL30424426 0.84 HDAC6 (0.52) HDAC6CDC7ROCK2GSK3BFLT3
SCHEMBL25355437 0.81 HDAC6 (0.52) HDAC6CDC7KDRHDAC1NAMPT
SCHEMBL25351569 0.79 HDAC6 (0.55) HDAC6CDC7ROCK2GSK3BPIM1
SCHEMBL25350232 0.79 HDAC6 (0.57) HDAC6CDC7ROCK2GSK3BPIM1
SCHEMBL24215731 0.78 HDAC6 (0.50) HDAC6CDC7ROCK2GSK3BFLT3
SCHEMBL30409172 0.78 HDAC6 (0.50) HDAC6CDC7ROCK2GSK3BFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116157398-B Oxadiazole-based selective histone deacetylase 6 inhibitors 意大发马克股份公司 2025-03-11 — — CN disclosed
CN-116157398-A 2- (4- ((5- (benzo [ b ] thiophen-3-yl) -1H-tetrazol-1-yl) methyl) phenyl) -5- (difluoromethyl) -1,3, 4-oxadiazole derivatives and similar compounds as selective inhibitors of histone deacetylase 6 (HDAC 6) for the treatment of, for example, peripheral neuropathy 意大发马克股份公司 2023-05-23 — — CN disclosed
Send feedback